|
Board of Directors
 |
Arnoud van Tulder (The Netherlands, 1961) Executive Director, Chief Executive Officer
Arnoud van Tulder previously held a position as the Vice President Corporate Accounting with Wolters Kluwer, a public information services and publishing company , before he joined Cryo-Save in August 2007. He is a qualified chartered accountant and worked for KPMG for over ten years. Arnoud van Tulder joined Cryo-Save in August 2007 as the Group’s Chief Financial Officer, and became Chief Executive Officer in May 2010.
|
 |
Marc Waeterschoot (Belgium, 1949) Executive Director
Marc Waeterschoot co-founded the Company in 2000 and has led its growth. Mr Waeterschoot is a qualified pharmacist and clinical pathologist having previously been a member of the board of directors of the state university of Ghent, Unilabs SA and DLCMC. He has over 35 years of industry expertise having managed and worked for a variety of healthcare companies, most notably Labo Medicom.
|
 |
Johan Goossens, (Monaco, 1955) Non-Executive Director, Chairman of the Board
Johan Goossens co-founded the Company in 2000 having gained over 20 years’ experience in private and investment banking, starting with KBC in 1979 and holding positions at a number of other institutions, including Nedee & Co, Defever and BNP-Naegelmackers. He left BNP-Naegelmackers in 1994 to focus on ‘Beurstips’, a weekly investment magazine published in Belgium, which he founded in 1992. This publication grew to be one of the most successful Belgian investor magazines and was sold by J. Goossens in 2005. J. Goossens holds a Bachelor of Economics degree from the High School of Ghent as well as a postgraduate qualification in marketing.
|
 |
Walter van Pottelberge (Belgium, 1944) Non-Executive Director
Walter van Pottelberge joined the Company’s Board as a Non-Executive Director in 2007. Mr. Van Pottelberge was Chief Executive Officer of ING Insurance Belgium-Luxembourg for eight years up until 2001. He was also president of the executive committee of Mercator Bank NV between 2003 and 2005. He served on the advisory board of Goffin bank between 2005 and 2009 where he was also Chairman of the Audit Committee. Mr. Van Pottelberge serves on various other company boards and organizations including Therasolve, Private Insurer (where he serves as chairman of the audit committee), VOKA, Gudrun, Argenta (where he serves as a member of the audit committee), Inventive Designers, Vanbreda, Justitia NV (where he serves as chairman of the audit committee), Vlerick Leuven Management School and the University of Antwerp. Mr. Van Pottelberge holds a university degree in physics and actuarial science from Leuven University.
|
 |
Ronald Lorijn (Switzerland, 1951) Non-Executive Director
Dr. Ronald Lorijn (MD, PhD, MBA), business consultant in biotechnology, joined the company as a Non-Executive Director in May 2010. Dr. Lorijn also serves on the board of Pepscan Therapeutics. Previously, Dr. Lorijn was Chief Executive of AMT NV (Amsterdam), having developed AMT from a small, one-product operation into a leading gene therapy company listed on the NYSE Euronext. He retired from AMT in February 2009. Prior to AMT, Dr. Lorijn worked at Amgen, a leading human therapeutics company, where he was part of Amgen Europe’s executive management team and responsible for its Clinical Operations, Business Development & Governmental Affairs. Before joining Amgen he was Chief Medical Officer and Senior Director of Clinical Operations & Medical Affairs, Europe at Centocor after having been employed by the pharmaceutical division of AKZO (Organon), as its head of worldwide Medical Services and Product Surveillance. Dr. Lorijn graduated from the Radboud University Nijmegen, completed a Ph.D. and was a certified obstetrician/gynecologist before joining the biotech industry. |
|
|
